Singapur - İngilizce - HSA (Health Sciences Authority)

kyowa kirin asia pacific pte. ltd. - romiplostim 375 μg/vial - injection, powder, for solution - romiplostim 375μg/vial (deliverable amt 250μg/vial) - romiplostim 375 μg/vial 250 μg/vial (deliverable amount)

Singapur - İngilizce - HSA (Health Sciences Authority)

pfizer private limited - dexmedetomidine hcl eqv dexmedetomidine base - injection - 100 mcg/ml - dexmedetomidine hcl eqv dexmedetomidine base 100 mcg/ml

Singapur - İngilizce - HSA (Health Sciences Authority)

ferring pharmaceuticals private limited - terlipressin acetate - injection, powder, for solution - 1 mg/vial - terlipressin acetate 1 mg/vial

Singapur - İngilizce - HSA (Health Sciences Authority)

ferring pharmaceuticals private limited - terlipressin 0.85 mg/8.5 ml eqv terlipressin acetate - injection, solution - 0.85 mg - terlipressin 0.85 mg/8.5 ml eqv terlipressin acetate 1 mg/8.5 ml

Malta - İngilizce - Medicines Authority

ferring pharmaceuticals limited drayton hall, church road, west drayton ub7 7ps, united kingdom - terlipressin acetate - powder and solvent for solution for injection - terlipressin acetate 0.2 mg/ml - pituitary and hypothalamic hormones and analogues

Malta - İngilizce - Medicines Authority

ferring pharmaceuticals limited drayton hall, church road, west drayton ub7 7ps, united kingdom - terlipressin acetate - solution for injection - terlipressin acetate 1 mg - pituitary and hypothalamic hormones and analogues

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - mizart is indicated for: - treatment of hypertension - prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - mizart is indicated for: - treatment of hypertension - prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: povidone; crospovidone; sodium hydroxide; lactose monohydrate; meglumine; colloidal anhydrous silica; magnesium stearate - telmisartan is indicated for:,treatment of hypertension ,prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: meglumine; lactose monohydrate; povidone; magnesium stearate; crospovidone; colloidal anhydrous silica; sodium hydroxide - telmisartan is indicated for:,treatment of hypertension ,prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.